高剂量与标准剂量的间歇性美罗在重症患者中的高剂量与标准剂量:观察性队列研究
Felix Bergmann1, Marlene Prager1,2, Lena Pracher1
1Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Annals of intensive care
|March 6, 2026
概括
与标准剂量相比,高剂量的美罗在重症患者中显著降低了90天的死亡率. 这项研究表明,高剂量的美罗可以改善重症患者的生存结果.
科学领域:
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 对重症患者的最佳美罗胺剂量尚未确立.
- 关于高剂量与标准剂量美洛对患者结局的影响存在不确定性.
研究的目的:
- 为了比较高剂量 (6克/天) 与标准剂量 (3克/天) 梅罗的有效性.
- 评估美罗胺剂量对重症患者90天死亡率和其他临床结果的影响.
主要方法:
- 在奥地利维也纳进行的观察性队列研究 (2014年3月至2024年3月).
- 包括重症患者在内的ICU停留时间≥3天,接受高剂量或标准剂量的meropenem治疗.
- 倾向性得分匹配 (2:1) 和共变量调整用于控制混因素.
主要成果:
- 与标准剂量组 (40.9%) 相比,高剂量美罗胺组 (31.5%) 的90天全因死亡率明显较低.
- 在30天死亡率,耐药性出现,ECMO启动或ARDS发病方面,没有观察到群体之间的显著差异.
- 高剂量治疗与急性损伤 (AKI) 的调整后风险较低有关.
结论:
- 高剂量间歇性美罗胺的使用独立地与危急病患者90天全因死亡率的降低有关.
- 这些发现表明,在这个患者群体中,高剂量美罗的潜在生存益处.
相关概念视频
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...


